Prolonged Oral Etoposide in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Author： Rose P.G. Blessing J.A. Van Le L. Waggoner S.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.70, Iss.2, 1998-08, pp. : 263-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Evaluation of Altretamine for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Arseneau J.

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 100-102

Academic Press

Access to resources Recommend Favorite

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Lewandowski G.S. Creasman W.T. Webster K.D.

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite

Prolonged Oral Etoposide in Recurrent or Advanced Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Soper J.T. Barter J.F.

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 267-271

Elsevier

Access to resources Recommend Favorite

Cisplatin and Pentoxifylline in Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

By Mannel R.S. Blessing J.A. Boike G.

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 64-66

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Prolonged Oral Etoposide in Advanced or Recurrent Carcinoma of the Cervix

By Morris M. Brader K.R. Burke T.W. Levenback C.F. Gershenson D.M.

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 215-218

Elsevier

Access to resources Recommend Favorite